News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Quest Diagnostics buys Celera
You may also be interested in...
Research In Brief
New findings on deep brain stimulation, ischemic stroke devices, orthopedics and more.
Covidien Aims To Double Sales In Emerging Markets By 2017
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm's Sept. 8 investor meeting in New York
Covidien Aims To Double Sales In Emerging Markets By 2017
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm’s Sept. 8 investor meeting in New York.